dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Rao, S. |
dc.contributor.author | Anandappa, G. |
dc.contributor.author | Dahan, L. |
dc.contributor.author | Evesque, L. |
dc.contributor.author | Kim, S. |
dc.contributor.author | Capdevila Castillon, Jaume |
dc.date.accessioned | 2022-09-15T07:07:16Z |
dc.date.available | 2022-09-15T07:07:16Z |
dc.date.issued | 2022-08 |
dc.identifier.citation | Rao S, Anandappa G, Capdevila J, Dahan L, Evesque L, Kim S, et al. A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202). ESMO Open. 2022 Aug;7(4):100529. |
dc.identifier.issn | 2059-7029 |
dc.identifier.uri | https://hdl.handle.net/11351/8196 |
dc.description | Inhibidor de PD-L1; Càncer anal; Retifanlimab |
dc.description.sponsorship | This work was supported by Incyte Corporation (Wilmington, DE, USA) (no grant number). |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | ESMO Open;7(4) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Anus - Càncer - Tractament |
dc.subject | Anticossos monoclonals - Ús terapèutic |
dc.subject.mesh | Anus Neoplasms |
dc.subject.mesh | Carcinoma, Squamous Cell |
dc.subject.mesh | Antibodies, Monoclonal, Humanized |
dc.title | A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202) |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.esmoop.2022.100529 |
dc.subject.decs | neoplasias del ano |
dc.subject.decs | carcinoma de células escamosas |
dc.subject.decs | anticuerpos monoclonales humanizados |
dc.relation.publishversion | https://doi.org/10.1016/j.esmoop.2022.100529 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Rao S, Anandappa G] The Royal Marsden, London, UK. [Capdevila J] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Teknon-IOB, Barcelona, Spain. [Dahan L] Hôpital de la Timone, Marseille, France. [Evesque L] Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. [Kim S] Centre Hospitalier Régional Universitaire de Besançon, Besançon, France |
dc.identifier.pmid | 35816951 |
dc.identifier.wos | 000829876500002 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |